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Lymph nodes (LNs) are at the center of adaptive immune responses. Various exogenous 
substances are transported into LNs and a series of immune responses ensue after rec-
ognition by antigen–specific lymphocytes. Although humanized mice have been used to 
reconstitute the human immune system, most lack LNs due to deficiency of the interleukin 
(IL)-2Rγ gene (cytokine common γ chain, γc). In this study, we established a transgenic 
strain, NOG-pRORγt-γc, in the NOD/shi-scid-IL-2Rγnull (NOG) background, in which 
the γc gene was expressed in a lymph-tissue inducer (LTi) lineage by the endogenous 
promoter of RORγt. In this strain, LN organogenesis was normalized and the number of 
human T cells substantially increased in the periphery after reconstitution of the human 
immune system by human hematopoietic stem cell transplantation. The distribution of 
human T cells differed between NOG-pRORγt-γc Tg and NOG-non Tg mice. About 40% 
of human T cells resided in LNs, primarily the mesenteric LNs. The LN-complemented 
humanized mice exhibited antigen-specific immunoglobulin G responses together and 
an increased number of IL-21+–producing CD4+ T cells in LNs. This novel mouse strain 
will facilitate recapitulation of human immune responses.
Keywords: humanized mice, nOg, lymph node, T cell, homeostasis
inTrODUcTiOn
Reconstitution of the human immune system in immunodeficient mice enables investigation of 
human immunology and facilitates drug discovery (1–3). Progress in humanized mouse technol-
ogy relies on extremely immunodeficient mouse strains; e.g., NOD-scid (4), NOD/Shi-scid IL2rγnull 
(NOG) (5), NOD/LtSz-scid IL2rγnull (NSG) (6), and BALB/c Rag2nullIL2rγnull (BRG) (7). These 
platform strains are characterized by a severe deficiency in the murine immune system. In addi-
tion to deficiency of B and T lymphocytes due to scid gene mutation or disruption of the RAG-2 
gene, especially, it is deletion of the interleukin (IL)-2 receptor γ (γc) gene that compromises the 
entire murine immune system. Because γc is a subunit for the receptors for six cytokines (IL-2, 
IL-4, IL-7, IL-9, IL-15, and IL-21) (8, 9), all biological pathways dependent on these cytokines are 
affected. In many cases, the primary consequences of the lack of γc are abnormal development 
and differentiation of lymphocytes; e.g., blocking of B-cell differentiation at the pre-proB  cell 
stage (10), severe reduction in the number of T cells, and total loss of natural killer cells (11–13). 
There are also indirect secondary effects; e.g., impaired development of lymph nodes (LNs) in 
γc-deficient mice (11).
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The organogenesis of LNs is complex and involves many cell 
types (14). One important cell type is the lymphoid tissue inducer 
(LTi) cell, which is a subpopulation in innate lymphoid cell 3 (15). 
During embryo development, LTi cells migrate toward lymphoid 
tissue stromal organizer (LTo) cells via a CXCL13-CXCR5–
dependent mechanism (16–18). The critical molecule in the 
interaction between LTi and LTo cells is lymphotoxin (LT), which 
triggers LN formation (14). Differentiation of LTi cells requires 
expression of the master transcription factor, RORγt (19). IL-7 is 
necessary for their survival, as the number of LTi cells is reduced 
in γc-deficient mice; this reduction in numbers is responsible 
for the poor LN development (20). The transgenic expression 
of mouse thymic stromal lymphopoietin (TSLP), an IL-7 family 
molecule, restores the number of LTi in γc-deficient mice, and 
such TSLP transgenic (Tg) mice in a γc-deficient background 
showed normal LN development (20). These results suggest the 
importance of interactions between LTi cells and cytokines in LN 
organogenesis.
Because LNs are the primary sites of induction of immune 
responses; i.e., influx of antigen–loaded dendritic cells and sub-
sequent activation of antigen-specific T- and B-cells resulting in 
germinal center formation, the absence of LNs could result in an 
immunodeficient status. Indeed, various mouse strains with no 
LNs—such as LTα−/− mice (21), LTβ−/− mice (22), or alymphop-
lasia mutant mice (aly/aly) (23), caused by a mutation in the NIK 
gene—show impaired or delayed immune responses. In addition, 
LNs are important for maintaining lymphocyte homeostasis (24).
Humanized NOG mice, which are produced by transplanting 
human CD34+ hematopoietic stem cells (HSCs), exhibit impaired 
LN development. In many cases, they have few small LNs even 
after full development of human B and T  lymphocytes. Thus, 
it is plausible that the immune responses in humanized mice 
are insufficient due to their poor LN organogenesis. Indeed, 
such mice are deficient in antigen-specific responses, especially 
antigen-specific antibody responses (25–27).
In this study, we developed a novel NOG strain with LNs. We 
used a bacterial artificial chromosome (BAC) clone containing 
the entire RORγt locus in which the first exon of RORγt was 
replaced with the murine γc gene. The transgenic mice showed 
normal LN development in the NOG genetic background. After 
transplantation of human HSCs, these mice showed a significant 
increase in the total number of human T cells, body-wide redistri-
bution of lymphocytes, and enhanced antibody production.
MaTerials anD MeThODs
Bac engineering
A BAC clone, RP23-263K17, containing the entire genomic region 
of the RORγ gene, was purchased from Advanced GenoTechs Co. 
(Tsukuba, Japan). BAC clone DNA was transfected into Escherichia 
coli EL250 by electroporation followed by homologous recombi-
nation (28). The whole cDNA of mouse γc and the polyA signal 
was introduced into the PL451 shuttle vector (28). The DNA 
fragment consisting of the murine γc and the neomycin resistance 
gene under the control of the PGK/EM7 promoter was amplified 
by Primestar GXL (Takara Bio Inc., Otsu, Japan). The PCR primer 
sequences are as follows: forward 5′-tgtgtgctgtcctgggctaccctact-
gaggaggacagggagccaagttctcagtcatgttgaaactattattgtcacc-3′, and 
reverse 5′-cctaggaatggtgacaggacccaggctcccccatgaccggatgcccccatt 
cacttacgctctagaactagtggatcc-3′.
The PCR products were introduced into EL250 with RP23-
263K17 to induce homologous recombination. After selecting 
chloramphenicol- and kanamycin-resistant colonies, we con-
firmed correct homologous recombination between the targeting 
vector and BAC DNA by sequencing and southern-blot analysis. 
The neomycin gene, which was flanked by flippase (FLP) recom-
binase target sequences, was removed by FLP-mediated site-
specific recombination by arabinose treatment. As a result, the 
murine γc gene was inserted into exon 1 of the RORγt gene. BAC 
DNA was purified using NucleoBond BAC100 (Macherey-Nagel, 
Dueren, Germany).
Mice and reconstitution with human 
stem cells
Mice were maintained in the animal facility at the Central 
Institute for Experimental Animals under specific-pathogen-
free conditions. All animal experiments were approved by the 
Institutional Animal Care and Use Committee (certification 
number 11004A) and were conducted according to the institu-
tional guidelines.
All of the experiments using human cells were approved by 
the Institutional Ethical Committee and conducted according to 
the guide lines.
Bacterial artificial chromosome transgenic B6 mice, which 
express murine γc under the control of RORγt regulatory ele-
ments, were generated in the C57/BL6 (B6) background. The BAC 
DNA described above was digested with PI-SceI and purified. 
The linearized DNA was microinjected into B6 fertilized eggs 
by the standard protocol. The obtained mice were genotyped by 
PCR and a founder mouse was used for backcross mating. After 
seven-time backcross mating to the NOG strain, we confirmed 
the replacement of the genetic background from B6 to NOD 
using microsatellite markers. NOG-GM-CSF/IL-3 transgenic 
mice (NOG-GM3 Tg) were described elsewhere (29).
For reconstitution of the human immune system, 6-week-
old male NOG or NOG-pRORγt-γc mice were irradiated with 
180 cGy of X-rays (MBR-1520R-4, Hitachi, Hitachi, Japan) and 
5 × 104 umbilical cord blood CD34+ cells (StemExpress, Folsom, 
CA, USA) were transplanted by intravenous injection the next 
day (hereafter, hu-HSC-NOG or hu-HSC NOG-pRORγt-γc, 
respectively).
antibodies and Flow cytometry
The following monoclonal antibodies (mAbs) were purchased 
from BioLegend (San Jose, CA, USA): anti-CD4-fluorescein 
isothiocyanate (FITC), anti-CD8a-FITC, anti-CD20-FITC, anti-
CD33-FITC, anti-CD19-phycoerythrin (PE), anti-CD21-PE, 
anti-CD3-PECy7, anti-IgD-PECy7, anti-CD8a-allophycocyanin 
(APC), antimouse CD45-APC, anti-CD4-APCCy7, anti-CD19 
APCCy7, and antihuman CD45-APCCy7.
To analyze human lymphocytes in mice reconstituted with 
the human immune system, multicolor cytometric analysis was 
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performed using a fluorescence-activated cell sorter (FACS) 
Canto (BD Biosciences). Peripheral blood (PB) was collected 
from the retro-orbital venous plexus using heparinized pipettes 
periodically under anesthesia with isoflurane to monitor the 
development of human cells. PB was also assessed using a blood 
analyzer (XT-2000i, SYSMEX, Kobe, Japan) to enumerate total 
white blood cells. Red blood cells were eliminated using ACK 
solution (150  mM NH4Cl, 10  mM KHCO3, 1  mM EDTA-Na2) 
and mononuclear cells (MNCs) were stained with fluorescent 
marker-conjugated antibodies for flow cytometry.
At the time of euthanasia, MNCs were prepared from the 
thymus, spleen, LNs, or bone marrow (BM) by smashing with 
frosted slide glasses, or by flushing the femurs with FACS 
medium [phosphate-buffered saline (PBS) containing 2% fetal 
calf serum (FCS) with 0.1% NaN3] using a 27-gage needle. The 
cells were stained with the relevant mAb cocktails for 20 min 
on ice, and washed with cold FACS medium. The proportion 
of each lineage was calculated using FACS Diva software (BD 
Biosciences) and the absolute number of each fraction was 
determined by multiplying the frequency by the total cell 
number.
For intracellular staining, cells were suspended in Roswell 
Park Memorial Institute (RPMI) medium (RPMI +  2% FCS) 
and stimulated with phorbol myristate acetate (50 ng/ml) and 
ionomycin (1 µg/ml) in the presence of Brefeldin A (BioLegend) 
for 4  h at 37°C, then fixed with fixation buffer (eBioscience, 
San Diego, CA, USA). After permeabilization with Cytofix/
Cytoperm solution (BD Biosciences), cells were stained with 
mAbs for anti-IFNγ-FITC, anti-IL-4-PE, and anti-IL-21-APC 
(BioLegend), together with antibodies for surface markers, for 
20 min on ice. After the final wash, the cells were subjected to 
flow cytometry.
Macroscopic analysis of lns
To visualize popliteal, inguinal, and sacral LNs, 1% Evans Blue 
dye (Sigma-Aldrich, St. Louis, MO, USA) was subcutaneously 
injected into the footpad or tail base. The mice were analyzed 
1  h after injection; LNs were evidenced by accumulation of 
Evans Blue. In some cases, LNs were detected by stereoscopic 
microscopy.
immunohistochemistry
Mouse tissues were fixed in Mildform (Wako, Osaka, Japan), 
embedded in paraffin and sectioned using a microtome. We 
used a mouse antihuman CD3 (PS1, Nichirei, Tokyo, Japan) or 
anti-CD20 (L26, Leica Microsystems, Tokyo, Japan) antibody 
for human T or B cells, respectively. The specimens were stained 
using a Leica BOND-MAX automated immunohistochemistry 
stainer (Leica Microsystems, Tokyo, Japan).
enzyme-linked immunosorbent assay 
(elisa)
The total plasma human immunoglobulin (Ig) M and IgG levels 
in reconstituted NOG or NOG-pRORγt-γc mice were meas-
ured by ELISA using a human Ig assay kit (Bethyl, Denver, CO, 
USA).
To assay ovalbumin (OVA)-specific IgG antibodies, hu-HSC-
NOG-GM-CSF/IL-3  Tg (NOG-GM3 Tg) or hu-HSC NOG-
pRORγt-γc/GM-CSF/IL-3 Tg (NOG-pRORγt-γc/GM3 Tg) mice 
were immunized at 12 weeks following HSC transplantation three 
times every 10 days with mixture of 10 µg OVA (Sigma-Aldrich) 
with 2 mg Alum (Cosmo Bio, Tokyo, Japan) by intraperitoneal 
injection. Plasma from the immunized mice was harvested 
4 days after the final immunization. Specific antibodies against 
OVA were measured by a standard method. Briefly, 96-well plates 
were coated with 5 µg/ml OVA at 4°C overnight. They were sub-
sequently washed and blocked with PBS containing 1% bovine 
serum albumin. The collected plasma samples were loaded after 
threefold serial dilution to 1:6,561 in blocking solution. An HRP-
conjugated antihuman Ig antibody was used as the secondary 
antibody. Anti-IgG- and -IgM-specific Abs were purchased from 
Bethyl. 3,3′,5,5′-Tetramethylbenzidine was used as a substrate 
for detection. The absorbance at 450 nm was measured using a 
microplate reader. The titer was defined as the dilution at which 
the absorbance of the sample became equivalent to that of non-
immunized mice.
resUlTs
restoration of Mouse ln Organogenesis 
in nOg-prOrγt-γc Tg Mice
To restore mouse LNs in the γc-deficient background, we 
attempted to express the mouse γc gene in an LTi-lineage-specific 
manner. Because RORγt is the critical master transcription 
factor for lineage specification, we generated a BAC transgenic 
strain in which expression of the γc gene was regulated by the 
endogenous control elements of the RORγt locus (Figure S1 
in Supplementary Material). First, we investigated whether 
B6-pRORγt-γc Tg mice exhibited rescued normal LN develop-
ment in the absence of the endogenous mouse γc gene. The Tg 
mice were crossed with γc-gene deficient mice (γc KO) to obtain 
the pRORγt-γc Tg in γc KO mice. Transgenic expression of the 
γc gene in the LTi-lineage restored LN development, which was 
absent in γc KO mice (Figure 1). After confirming the ability to 
stimulate LN organogenesis, we subsequently produced NOG-
pRORγt-γc Tg mice (NOG-pRORγt-γc Tg) by backcrossing, 
and LN development in the NOG background was assessed 
(Figures 2A,B).
Macroscopic analysis revealed that most LNs were restored, 
although there were variances in the degree depending on the 
location. For example, restoration of cervical, mediastinal, 
and pyloric/pancreatic LNs was evident in almost 100% of 
NOG-pRORγt-γc Tg mice. The frequencies in NOG-non 
Tg mice of the same LNs were 30, 0, and 40%, respectively 
(Figure  2B). More than 80% of NOG-pRORγt-γc Tg mice 
had brachial, inguinal, and lumbar LNs, compared to 40, 0, 
and 5%, respectively, in NOG-non Tg mice. Axillary, sacral, 
and popliteal LNs were detected in about 50% of Tg mice, 
compared to 10, 0, and 0%, respectively, in NOG-non Tg 
mice. Renal LN development was not evident even in the Tg 
mice (Figure  2B). Another distinct feature of the Tg mice 
was enlargement of the mesenteric LNs (mLNs; Figure  2A). 
FigUre 2 | Restored lymph nodes (LNs) in NOG mice. (a) LNs in NOG-pRORγt-γc Tg and NOG non-Tg mice. Evans Blue was subcutaneously administered into the 
tail base or foot pad for visualization of draining LNs (left panels). Red circles indicate inguinal, axillary/brachial, and popliteal LNs. Representative mesenteric LNs (mLNs) 
from NOG-pRORγt-γc Tg and NOG non-Tg mice are shown in the right panel. Two distinct LNs from NOG mice are circled in red. (B) Efficiency of LN restoration in 
NOG–pRORγt-γc Tg mice. NOG-pRORγt-γc Tg or NOG non-Tg mice were examined for the presence of tissue-associated LNs. For scoring, the number of LNs in each 
tissue from individual mice was counted and the ratio to the number of the corresponding tissue-associated LNs in wild-type NOD mice was calculated. Mean ± SD 
from NOG-pRORγt-γc Tg (n = 9) and NOG non-Tg mice (n = 15). Student’s t-test was performed to assess statistical significance (*p < 0.05 and **p < 0.01).
FigUre 1 | Induction of lymph node (LN) organogenesis in γc-deficient mice using the pRORγt-γc transgene. A bacterial artificial chromosome (BAC)-transgenic 
(Tg) male founder mouse was crossed with female NOD/shi-scid-IL-2Rγnull (NOG) mice. The presence of LNs in the F1 mice was macroscopically confirmed. Red 
circles indicate inguinal LNs (top panels) and para-aortic LNs in the abdomen (bottom panels).
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FigUre 3 | Colonization of restored lymph nodes (LNs) by human lymphocytes. (a) The indicated LNs were isolated from NOG-pRORγt-γc Tg mice at 20 weeks 
after hematopoietic stem cell transfer, and human lymphocytes were analyzed by fluorescence-activated cell sorting (FACS). A representative result from three 
different mice is shown. (B) Immunohistochemistry of mLNs. mLNs from the same mice used in (a) were fixed in formalin and sectioned after embedding  
in paraffin. Sections were stained with antihuman CD3 (left) and CD20 (right) antibodies.
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Whereas NOG-non Tg mice had two small distinct mLNs, 
Tg mice had a consecutive form of mLNs similar to those in 
WT mice (Figure  2A). However, we did not detect Peyer’s 
Patches (data not shown).
To examine whether human lymphocytes could migrate and 
colonize the restored LNs of NOG-pRORγt-γc Tg mice, Tg mice 
were X-irradiated and transplanted with HSCs. After confirm-
ing development of human T cells in PB at 20 weeks post-HSC 
transplantation, we isolated LNs and analyzed the MNCs in the 
LNs by flow cytometry. Human lymphocytes were detected in 
all LNs. The subsets of human lymphocytes differed depending 
on the LN location. Although a considerable number of human 
B cells were detected in most of the LNs, the brachial, axillary, 
and popliteal LNs contained a few human B  cells, 0–5% in 
human CD45+ cells. All LNs contained both human CD4+ and 
CD8+ T cells (Figure 3). Histological analysis of LNs showed a 
disorganized structure with a diffuse T-cell distribution rather 
than clear segregation of the B- and T-cell zones (Figure 3B). The 
disorganized structure was similar to that in NOG-non Tg mice 
(Figure S2 in Supplementary Material). We could not isolate a 
measurable number of human cells from the intestinal lamina 
propria in spite of the enlarged mLN in NOG-pRORγt-γc Tg 
mice (data not shown).
Development of human lymphocytes  
in nOg-prOrγt-γc Tg Mice
Human hematopoiesis was compared between NOG-non Tg and 
NOG-pRORγt-γc Tg mice. PB MNCs were analyzed 8–16 weeks 
after HSC transplantation (Figure 4). The frequency and number 
of human CD45+ cells did not differ between the two strains 
(Figure  4A). The development and differentiation of human 
CD33+ CD45+ myeloid cells were also comparable between 
non-Tg and pRORγt-γc Tg mice (data not shown). With respect 
to human lymphocytes, the development of human CD45+ 
leukocytes was not different at 8  weeks post-HSC transplanta-
tion. However, the frequency and absolute number of human 
T cells was significantly higher in pRORγt-γc Tg mice than in 
non-Tg mice at 12 weeks after HSC transplantation (Figure 4C). 
Although the frequency of human B cells was lower in Tg mice 
than in non-Tg mice, the absolute number of human B  cells 
was not different (Figure 4B). Reflecting the increase in human 
FigUre 4 | Development of human leukocytes in NOG-pRORγt-γc Tg mice. Peripheral blood (PB) was collected at the indicated time points after hematopoietic 
stem cell transfer. A portion was used for enumeration of total mononuclear cells. The remaining blood was subjected to fluorescence-activated cell sorter (FACS) 
for human leukocytes. (a) Frequency and absolute number of human CD45+ cells in total mononuclear cells. (B,c) Frequencies and absolute numbers of human 
B (B) and human T (c) cells among human CD45+ cells. Cellularity was calculated by multiplying the number of total mononuclear cells by the frequencies of each 
human subpopulation determined by FACS. (D) Kinetic change of the human T to B cell ratio. Mean ± SD from NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg 
mice (n = 11). Student’s t-test was performed to assess statistical significance (*p < 0.05 and **p < 0.01). A representative result from three independent 
experiments is shown.
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T cells, the T:B ratio was higher in Tg mice than in non-Tg mice 
at 12 and 16 weeks after HSC transfer (Figure 4D).
Analysis of the BM at 16  weeks after HSC transplantation 
demonstrated that the frequency and absolute number of human 
CD45+ leukocytes were higher in non-Tg mice than in Tg mice 
(Figure S3 in Supplementary Material). There were no significant 
differences in the frequencies and numbers of human CD19+ cells, 
which include human immature and mature B lineage cells, and 
human CD3+ T cells (Figure S3 in Supplementary Material). In 
the thymus, there was no significant difference in the cellularity 
of human thymocytes (Figure 5A). Analysis of subpopulations 
showed a significant reduction in the frequency of CD4+CD8+ 
thymocytes in NOG-pRORγt-γc Tg mice compared with non-Tg 
mice. In contrast, the frequencies of CD4+CD8− and CD4−CD8+ 
thymocytes were higher in NOG-pRORγt-γc Tg mice than in 
NOG-non-Tg mice (Figure 5B). However, the absolute numbers 
of these subpopulations were not significantly different due to the 
large variances in the total number of thymocytes (Figure 5C). 
FACS analysis of splenocytes demonstrated that the frequency 
and absolute number of human CD45+ cells were not different 
irrespective of LN restoration (Figure 6A). A considerable por-
tion of human CD19+ cells in hu-HSC NOG mice are immature 
B  cells, including transitional B  cells, and they do not express 
CD20 or CD21 (27). Thus, to examine the maturation of human 
B cells in NOG-pRORγt-γc Tg mice, we compared the frequency 
and number of the CD19+CD20+CD21+ subpopulation between 
NOG-pRORγt-γc Tg and NOG-non-Tg mice. While the 
frequency of mature human B cells was higher in non-Tg than 
in Tg mice, there was no significant difference in the absolute 
number (Figure 6B). In contrast, the frequency of human T cells 
was significantly higher in Tg than in non-Tg mice. We did not 
detect a significant difference in the cellularity of human T cells 
(Figure 6C). The human B to T cell ratio was comparable between 
Tg and non-Tg mice (Figure 6D). Regarding T cell subsets, the 
ratio of CD4+ to CD8+ T cells was not altered by the presence of 
LNs (Figure 6E).
We next examined LNs and found that pRORγt-γc Tg mice 
showed remarkable enlargement of mLNs. The weight of the 
FigUre 5 | Analysis of human cells in the thymus. Thymocytes were prepared from the thymi of NOG-pRORγt-γc Tg and NOG non-Tg mice at 24 weeks after 
hematopoietic stem cell transplantation and analyzed by fluorescence-activated cell sorting. (a) Absolute numbers of human thymocytes. (B,c) The frequencies of 
human CD4+CD8+ double positive, CD4+CD8−, and CD4−CD8+ single positive cells in human thymocytes (B) and the absolute numbers of each cell subpopulation 
(c). Mean ± SD of NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg mice (n = 11). Asterisk indicates statistical significance (p < 0.05).
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mLNs in pRORγt-γc Tg mice was about eightfold higher than 
that in non-Tg mice (Figure 7A). Because other LNs were smaller 
than the mLNs, all LNs other than the mLNs were pooled for 
analysis; mLNs were analyzed separately. Reflecting the increase 
in weight, mLNs in NOG-pRORγt-γc Tg mice contained a sig-
nificantly larger number of human leukocytes, which included 
both human CD19+ B cells and CD3+ T cells, than non-Tg mice 
(Figure 7B). The frequency of human CD45+ cells in total MNCs 
was not influenced, suggesting that mouse CD45+ cells were pro-
portionally increased (Figure 7B). The T:B cell ratio was higher 
in Tg mice than in non-Tg mice (Figure 7C). As in the spleen, 
the CD4 to CD8 ratio was not different between Tg and non-Tg 
mice (Figure 7D).
An increased number of human leukocytes, including human 
CD19+ B and CD3+ T  cells, in NOG-pRORγt-γc Tg mice was 
also observed in other tissue-associated LNs (Figure  8A). The 
frequency of human CD45+ cells was not influenced in tissue-
associated LNs as in mLNs (data not shown). The ratio of these 
two populations remained unchanged between non-Tg and Tg 
mice (Figure  8A). The proportions of CD4+ and CD8+ T  cells 
in CD3+ T cells also did not differ between non-Tg and Tg mice 
(Figure 8A).
After determining the absolute number of human lymphocytes 
in secondary lymphoid organs (spleen, LNs, and mLNs), the total 
number of human cells in the whole mouse was calculated. There 
was no significant difference in the human CD45+ cell number 
between non-Tg and Tg mice (Figure 8B). Interestingly, the total 
number of human CD3+ T cells increased about threefold in Tg 
mice compared to non-Tg mice (Figure 8B), while the number of 
human CD19+CD20+CD21+ mature B cells was not significantly 
different (Figure 8B). Accordingly, the T to B cell ratio was higher 
in NOG-pRORγt-γc Tg mice than in NOG-non-Tg mice. Due to 
the migration of human lymphocytes into LNs, the lymphocyte 
tissue distribution differed markedly between NOG-pRORγt-γc 
Tg mice and non-Tg mice. In normal NOG non-Tg mice, almost 
90% of human T cells resided in the spleen. In contrast, ≤60% 
of human T cells were present in the spleen in Tg mice, and ~30 
and 10% of human T cells migrated into mLNs or other tissue-
associated LNs, respectively (Figure 8C). Mature human B cells 
were also distributed primarily in LNs (data not shown).
FigUre 6 | Analysis of human cells in the mouse spleen. Splenocytes were prepared from the spleens of NOG-pRORγt-γc Tg and NOG non-Tg mice for 
fluorescence-activated cell sorting analysis at 24 weeks after HSC transplantation. (a) Frequency and absolute number of human CD45+ cells in total mononuclear 
cells. (B,c) Frequencies and absolute numbers of human CD19+ B cells (B) and human CD3+ T cells (c) among human CD45+ cells. (D) Human T to B cell ratio  
in human CD45+ cells. (e) The CD4+ T cell to CD8+ T cell ratio in human T cells. Mean ± SD from NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg mice (n = 11). 
Asterisk indicates statistical significance (*p < 0.05).
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augmentation of humoral immune 
responses in nOg-prOrγt-γc Tg Mice
To examine the immunological features of hu-HSC NOG-
pRORγt-γc Tg mice, serum total human IgM and IgG levels were 
quantified by ELISA. The IgM level was equivalent in non-Tg 
and Tg mice, whereas the IgG level was significantly higher in 
Tg mice than in non-Tg mice (Figure 9A). Next, we investigated 
whether LN-sufficient humanized mice could induce antigen-
specific humoral immune responses. Impaired production of 
antigen-specific IgG responses in humanized mice has been 
reported, likely due to the lack of cognate interactions between 
mouse major histocompatibility complex (MHC)-restricted 
human T cells and human leukocyte antigen (HLA) on human 
B cells (30, 31). However, antigen-specific IgG responses could 
be facilitated by crosstalk between antigen-specific B and T cells 
in LNs. To further improve the probability of human immune 
responses, we used transgenic mice the GM-CSF/IL-3 transgenic 
NOG (NOG-GM3 Tg). This strain allowed the development 
of various lineages of human cells, including lymphoid and 
myeloid cells, from HSCs (29). Those human cells could facilitate 
induction of immune responses. After reconstitution of NOG-
pRORγt-γc/GM3 Tg or NOG-GM3 Tg mice with the human 
immune system, we immunized the animals with OVA/Alum 
complex. The OVA-specific human IgG titer was significantly 
higher in NOG-pRORγt-γc/GM3 Tg than in NOG-GM3 Tg 
mice (Figure 9B), and was ~250-fold higher than that in non-
immunized mice. Although we expected that improved human 
hematopoiesis enhanced antigen-specific antibody responses 
in NOG-GM3 Tg mice, the induction of OVA-specific IgG was 
modest. Next, we investigated the production of IL-4 and IL-21 
by CD4+ T cells, because these cytokines are important for pro-
moting class switching and plasma cell differentiation (32, 33). 
The frequency of IL-21+ CD4+ T cells was significantly higher in 
mLNs from NOG-pRORγt-γc/GM3 Tg than NOG-GM3 Tg mice 
FigUre 7 | Analysis of mesenteric lymph nodes (mLNs). (a) Weight of mLNs. mLNs were isolated at 24 weeks after hematopoietic stem cell transplantation. 
Representative photographs of mLNs from human HSC-engrafted NOG-pRORγt-γc Tg and non-Tg mice. (B) Frequency and absolute number of human leukocytes. 
Human mononuclear cells were isolated from mLNs and analyzed by fluorescence-activated cell sorting. The number of human CD45+ leukocytes was obtained by 
multiplying the total number of mononuclear cells by the frequency of human CD45-positive cells. (c) Human T to B cell ratio. (D) Human CD4+ T cell to CD8+ T cell 
ratio. Mean ± SD from NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg mice (n = 11). Student’s t-test was performed to assess statistical significance (*p < 0.05 and 
**p < 0.01).
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(Figure 9C), but this was not the case in splenic CD4+ T cells from 
the same animals. There were no differences in the frequency 
of IFNγ-, IFN-17-, and IL-4–producing CD4+ T  cells between 
NOG-pRORγt-γc/GM3 Tg and NOG-GM3 Tg mice (Figure S4 
in Supplementary Material). A standard immunophenotyping 
protocol using chemokine receptor expression also confirmed 
the increase of CD3+CD4+CD5RA−CXCR5+ follicular helper 
T cells (Tfh) in frequency (34) and there was no difference in the 
frequency of FOXP3+ CXCR4+CD25+ CD4+ human regulatory 
T cells (Treg) in CD4+ T cells between NOG-pRORγt-γc Tg and 
non-Tg mice (Figure S5 in Supplementary Material) (35). These 
results suggest that the composition of T cell subsets was gener-
ally maintained in NOG-pRORγt-γc Tg mice except the increase 
of IL-21+ producing Tfh cells. It should be noted, however, that 
the absolute cell number of each subset significantly increased 
reflecting the increase of total CD4+ T cells.
DiscUssiOn
In this study, we demonstrated that LN organogenesis could be 
restored in NOG mice by expressing the mouse γc gene under 
the control of the RORγt promoter, and that these LNs function 
as a reservoir for human lymphocytes after reconstitution of 
the human immune system. Furthermore, our results showed 
that restored LNs could confer immunological competence on 
humanized NOG mice.
To restore LN development in NOG mice, we generated a 
NOG transgenic strain expressing human TSLP. This approach 
was not successful, however, in the NOG background, as our 
NOG transgenic strain expressing the human TSLP gene, which 
possesses about 42% homology with the mouse TSLP gene, devel-
oped severe thymoma, which resembled the disease frequently 
seen in NOD-scid mice (data not shown) (36). It is possible that 
cytokine signaling through mouse IL-7Rα or mouse TSLP recep-
tor stimulated oncogenic mechanisms intrinsic to mice with the 
NOD background. The efficiency of LN restoration was greater in 
TSLP Tg γc-KO mice than in NOG-pRORγt-γc Tg mice. Indeed, 
some NOG-pRORγt-γc Tg mice showed unilateral development 
of axillary, brachial, inguinal, or popliteal LNs, while the TSLP 
Tg γc-KO mice showed almost 100% LN organogenesis (20). 
It is possible that the expression level of γc in LTi cells was not 
sufficient for full recovery of this lineage, resulting in partial 
FigUre 8 | Analysis of lymph nodes (LNs) and distribution of human T lymphocytes. (a) Absolute number of human leukocytes in tissue-associated LNs. Human 
mononuclear cells were prepared from pooled LNs from NOG-pRORγt-γc Tg and NOG non-Tg mice at 24 weeks after hematopoietic stem cell transplantation.  
(Left panels) Numbers of human CD45+ leukocytes (upper), human B cells (middle), and human T cells (bottom) were calculated by multiplying the total number of 
mononuclear cells by the frequency of each fraction. (Right panels) The human T to B cell ratio (upper panel) and human CD4+ T cell to CD8+ T cell ratio (bottom 
panel). (B) Total number of human leukocytes in secondary lymphoid organs. Data from the spleen, LNs, and mesenteric LNs were summed for human CD45+ 
leukocytes (upper left), human B cells (upper right), and human T cells (bottom left). The human T to B cell ratio in all lymphoid organs is also shown (bottom right). 
(c) Distribution of human T cells. The proportion of human T cells in each secondary lymphoid organ was calculated. Mean ± SD from NOG-pRORγt-γc Tg (n = 12) 
and NOG non-Tg mice (n = 11). Statistical significance was evaluated by Student’s t-test (**p < 0.01).
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development of LNs in NOG-pRORγt-γc Tg mice. Supporting 
this hypothesis, although we detected significant increase of the 
frequency and number of LTi cells in NOG-pRORγt-γc Tg mice 
compared with NOG-non-Tg mice. However, the increase was 
not more than twofold in number (Figure S6 in Supplementary 
Material). This may also explain the lack of Peyer’s patches. Mice 
with constitutive expression of the mouse γc gene with strong 
promoters could results in the better restoration of LN develop-
ment and Peyer’s patches. As a result, such strains, an equivalent 
strain to NOD-scid mice, may have better organized LN structures 
and elicit better immune responses like in NOD-scid mice (37). 
However, at the expense of the benefit, such strains may develop 
thymoma (36). In addition, they may have various lymphoid 
lineages which reduce the efficiency of engraftment of human 
hematopoietic cells (38).
Humanized mice generated by simple transfer of human 
cord blood-derived HSCs exhibit suboptimal immune responses 
(1). These weak immune reactions can be in part explained 
by inefficient development of human T  cells by the atrophic 
mouse thymus, lack of HLA-restriction of human T cells (27), 
incomplete maturation of human B cells (27), or accumulation 
of human T cells susceptible to cell death by antigen stimulation 
(27). These problems have been addressed by various approaches. 
For example, administration of recombinant human Fc-IL-7 
protein (39) or lentiviral delivery of human IL-7 increased 
T-cell numbers (40). HLA-matching between HSC donor and 
recipient mice by introducing HLA transgenes into mice induced 
HLA-restricted human immune responses (30, 31, 41, 42). As 
an alternative approach to overcome the limitations inherent to 
humanized mice, we examined whether restoration of LNs would 
improve human lymphocyte homeostasis and human adaptive 
immune responses.
Preferential expansion of human T cells was evident in NOG-
pRORγt-γc Tg mice. In addition, restoration of LNs induced a 
FigUre 9 | Enhanced humoral responses in NOG-pRORγt-γc Tg mice. (a) Total IgM and IgG levels in plasma. Plasma was prepared 24 weeks after hematopoietic 
stem cell (HSC) transplantation and total IgM and IgG levels were quantified by enzyme-linked immunosorbent assay (ELISA). Mean ± SD from NOG-pRORγt-γc Tg 
(n = 12) and NOG non-Tg mice (n = 11). Statistical significance was evaluated by Student’s t-test (**p < 0.01). (B) ELISA results for ovalbumin (OVA)-specific human 
IgG. NOG-pRORγt-γc/GM-CSF/IL-3 Tg (ROR/GM3) (n = 6) or NOG-GM-CSF/IL-3 Tg (GM3) (n = 7) mice were transplanted with HSCs. After confirming T-cell 
differentiation in the peripheral blood at 12 weeks post-HSC engraftment, mice were immunized three times with OVA/Alum. Plasma was collected 4 days after the 
final boost. Titers of individual mice are shown. Statistical significance was evaluated by Student’s t-test (**p < 0.01). (c) Increase in the number of IL-21-producing 
CD4+ T cells in lymph nodes (LNs). Spleen and mesenteric LNs from OVA-immunized NOG-ROR/GM3 or NOG-GM3 mice were stimulated with phorbol myristate 
acetate/ionomycin for 4 h in the presence of Brefeldin A. Cytokines were stained after fixation and permeabilization. Mean ± SD frequencies of IL-21+ CD4+ T cells 
among total CD4+ T cells. Statistical significance was evaluated by Student’s t-test (*p < 0.05).
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significant redistribution of human lymphocytes from the spleen 
to the LNs. Indeed, almost 40% of total human T cells were mobi-
lized into LNs in NOG-pRORγt-γc Tg mice, mostly to the mLNs. 
The macroscopic analysis demonstrated that the weight of the 
mLNs in NOG-pRORγt-γc Tg mice was eightfold higher than 
that in NOG non-Tg mice, and they harbored ~35% of the total 
human T cells. Although the reason for the preferred residence 
of human T cells in mLNs is unclear, not only simple migration 
but also homeostatic proliferation may be strongly induced in the 
enlarged mLNs in NOG–pRORγt-γc Tg mice. This seems to be 
mediated by thymus-independent mechanisms, as the numbers 
of thymocytes were not different between Tg and non-Tg mice. 
By draining the small intestine and colon, mLNs provide human 
T  cells with abundant and non-competitive signals, which 
include pMHC, cytokines, and physical space. Thus, mLNs may 
have a marked impact on the homeostasis of human T cells. In 
contrast to the increase in the number of human T cells, the effect 
on human B  cells was unremarkable. The absolute number of 
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human mature B  cells was not significantly different between 
NOG-pRORγt-γc Tg and NOG non-Tg mice. Although the 
development of human T  cells and the maturation of human 
B  cells is reportedly correlated in humanized mice, the robust 
increase in human T cell number did not result in an increase in 
that of human mature B cells in NOG-pRORγt-γc Tg mice (43). 
Furthermore, histological analysis showed incomplete architec-
ture of LNs, which lacked B-cell follicles and germinal centers. 
The persistent blockage of B cell maturation suggests that LNs 
do not provide an environment conducive to full maturation of 
human B cells. Considering the abundant T cells in LNs, T cell-
independent factors may be necessary for B cell maturation. Our 
immunohistochemistry showed that mouse follicular dendritic 
cells (FDCs) were not induced in mLNs (data not shown). 
This may be due to the absence of interaction between mature 
human B  cells and mouse FDC progenitor cells. Alternatively, 
human FDCs, which were of non-hematopoietic origin, may be 
necessary for inducing maturation of human B  cells and thus 
organizing LN structures.
The serological analysis demonstrated induction of a partial 
human humoral immune response in the LN-sufficient human-
ized mice, despite the lack of HLA-II molecules. Introduction 
of HLA-DR molecules in recipient mice and matching of the 
HLA-DR haplotype between the recipient mice and HSC donors 
are essential for induction of antigen-specific IgG responses in 
humanized mice (30, 31). The importance of HLA-II in recipient 
mice was also confirmed in this study using NOG-GM/3 Tg mice, 
which did not show antigen-specific IgG responses despite dif-
ferentiation of multiple types of human antigen-presenting cells, 
including dendritic cells, macrophages/monocytes, and B cells, 
in the spleen. Although the mechanisms for the induction of 
antigen-specific IgG responses in LN-restored humanized mice 
are unclear, the increases in the frequency of IL-21 producing 
CD4+ T cells and the total number of CD4+ T cells in LNs suggest 
that an IL-21-rich milieu is generated in LNs, which induces IgG 
class switch recombination in B cells in the vicinity, even in the 
absence of cognate interactions with T cells with the same anti-
gen specificity. Introduction of HLA-II molecules may further 
enhance antibody production.
In this study, we developed a novel NOG substrain with 
immunologically competent LNs. The enhanced immune 
responses of NOG-pRORγt-γc Tg mice will be useful, particu-
larly in combination with HLA Tg or human cytokine-gene 
introduced mouse strains. This would synergistically enhance 
the quasihuman immune response and facilitate development of 
novel vaccines against infectious diseases and immunotherapies 
for tumors.
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FigUre s1 | Schematic of bacterial artificial chromosome recombination for 
expression of mouse interleukin 2Rγ under the control of the regulatory elements 
of mouse RORγt.
FigUre s2 | Immunohistochemistry of mesenteric lymph node in hu-HSC 
NOG-non Tg mice.
FigUre s3 | Analysis of human cells in the bone marrow (BM). BM from 
NOG-pRORγt-γc Tg and NOG non-Tg mice were isolated from the tibiae  
and analyzed by fluorescence-activated cell sorting (FACS). (a) Frequency  
and absolute number of human CD45+ cells among total mononuclear cells.  
(B,c) Frequencies and absolute numbers of human CD19+ B cells (B) and 
human CD3+ T cells (c) among human CD45+ cells. Mean ± SD from 
NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg mice (n = 11).
FigUre s4 | Frequency of human Th1, Th2, and Th17 cells in hu-HSC 
NOG-pRORγt-γc Tg. The mesenteric lymph node cells used in Figure 9 were 
stained for human IFN-γ (Th1 cells), IL-4 (Th2 cells), and IL-17 (Th17 cells).
FigUre s5 | Subpopulation in CD4+ T cells. Spleen and mesenteric lymph 
node in NOG-pRORγt-γc Tg and NOG-non-Tg mice were analyzed at  
16weeks after hematopoietic stem cell transplantation (n = 4). Th1 cells, Th17, 
or Tfh cells were defined as CD3+CD4+CD45RA−CXCR5−CXCR3+CCR6−, 
CD3+CD4+CD45RA−CXCR5−CXCR3−CCR6+, or CD3+CD4+CD45RA−CXCR5− 
cells. Human regulatory T cells were defined as FOXP3+CCR4+CD25+CD4+ 
T cells. For immunophenotyping, following antibodies were used for staining 
and analyzed by a BD LSR Fortessa X-20 cell analyzer (BD Biosciences). 
Anti-CCR7-Brilliant Violet 421, anti-CD45-BV510, anti-CXCR3-APC, anti-CD4-
APC, anti-CD45RA-APCCy7, anti-CCR6-PE, anti-CD4-PECy7, anti-CCR4-
PECy7, and antimouse CD45-PerCP-Cy5.5 were from BioLegend. Anti-
CXCR5-Brilliant Blue 515, anti-CD25-BB515, and anti-CD3-Brilliant Ultraviolet 
737 were from BD Biosciences. Dead cells were excluded by 7-AAD (Beckman 
Coulter). Intracellular staining of FOXP3 was conducted using Anti-Human 
Foxp3 staining Set phycoerythrin from eBioscience according to the 
manufacturer’s instruction. Student’s t-test was performed to assess  
statistical significance (*p < 0.05).
FigUre s6 | Increase of LTi cells in NOG-pRORγt-γc Tg. The presence  
of LTi was examined in embryo of NOG-pRORγt-γc Tg and NOG-non-Tg 
mice at E15. The fetal intestine was smashed with a pestle and mononu-
clear cells were stained with a cocktail of antibodies; antimouse CD3-FITC, 
antimouse CD4-PE, antimouse B220, antimouse CD127 (IL-7Rα)-APC, and 
antimouse CD45-APC-Cy7. LTi cells were defined as CD4+CD127+ cells in 
CD45+CD3−B220− cells. A part of embryo was used for genotyping by PCR. 
Mean ± SD from NOG-pRORγt-γc Tg (n = 12) and NOG non-Tg mice 
(n = 14). Student’s t-test was performed to assess statistical significance 
(*p < 0.05).
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